Peps
What is Sermorelin?
Sermorelin is a growth-hormone-releasing-hormone fragment with a historical pediatric medicine record. That history needs to be distinguished from current wellness marketing.
Biological role or research focus
Growth hormone-releasing hormone fragment.
A historical Geref regulatory determination does not establish the approval status of a current seller formulation.
Names you may encounter
sermorelin acetate · Geref
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- GHRH(1–29) peptide
- Main research area
- Pituitary growth-hormone signaling
- Evidence featured
- Human open-label study
- Source check
- October 4, 2026
Molecular structure
Mechanism & research rationale
It stimulates release of growth hormone through the pituitary pathway. Response depends on the underlying endocrine system and is not equivalent to administering growth hormone itself.
Research context & status
A 2013 FDA determination stated that discontinued Geref products were not withdrawn for safety or effectiveness reasons. It does not confer approval on a current compounded or research seller’s preparation.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Human open-label study · 1996
Geref pediatric growth study
Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.
- Population / model
- 110 previously untreated children with growth-hormone deficiency; 86 eligible for efficacy analysis.
- Study design
- Multicenter treatment for up to one year, measuring height velocity and safety.
- Main finding
- Average height velocity increased from 4.1 cm/year at baseline to 7.2 cm/year at 12 months.
- Limits & context
- There was no blinded placebo comparison. Growth in hormone-deficient children cannot establish anti-aging, body-composition, or performance benefits in adults.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. ↗
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 Jan 1 · Journal Article, Review
Read available full text ↗
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. ↗
Sports medicine (Auckland, N.Z.) · 2026 Aug · Journal Article, Review
Advances in the detection of growth hormone releasing hormone synthetic analogs. ↗
Drug testing and analysis · 2021 Nov · Journal Article, Validation Study
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. ↗
The Journal of sports medicine and physical fitness · 2026 Jul · Journal Article, Review
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety evidence & remaining uncertainty
The pediatric growth study provides limited safety observations in that setting. It cannot establish adult anti-aging safety, particularly with different formulations or other hormone-active treatments.
Source: FDA · Geref determination (2013) ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
7 matching video records · 1 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Peptide Of The Week
Telehealth vs Research Peptides: The Truth Nobody Tells You | Peptide of the Week Q&A #61 ↗
Captions indexed · Automatic matches need review
Biohackingturkey
Sermorelin Asetat Nedir? 1 Dakikada Gerçekler ↗
Title match · Captions not indexed
Biohackingturkey
Sermorelin Gerçekten Daha Güvenli Bir HGH mi? Doktor Açıklıyor ↗
Title match · Captions not indexed
Biohackingturkey
Sermorelin Nedir? Yaşlanmayı Durduran Hormon Rehberi ↗
Title match · Captions not indexed
Dr. Jones, DC
Is Sermorelin Actually a “Safer HGH” (Doctor Explains) ↗
Title match · Captions not indexed
Dr. Jones, DC
The Smarter GH Option #sermorelin #growthhormone ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
SERMORELIN (5 mg)
American Peptides · Vendor-labeled research use only
$60.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Sermorelin (10 mg)
PSPeptides · Vendor-labeled research use only
$79.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Is the speaker citing a historical product or a current formulation?
- What current source supports the exact product claim?
- A historical Geref regulatory determination does not establish the approval status of a current seller formulation.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Does historical Geref approval validate every sermorelin product today?
No. Regulatory status belongs to the specific product.
Does childhood height improvement prove adult muscle or longevity benefits?
No. Different populations and outcomes require their own evidence.
References & editorial record
- FDA · Geref determination (2013) ↗
- Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. ↗
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.